Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-100
Closed -$96 11276
2025
Q4
$96 Buy
+100
New +$127 ﹤0.01% 10194
2025
Q2
Sell
-5,075
Closed -$10.7K 10919
2025
Q1
$10.7K Sell
5,075
-1,355
-21% -$2.89K ﹤0.01% 8606
2024
Q4
$15K Buy
+6,430
New +$9.67K ﹤0.01% 8061
2024
Q1
Sell
-1,522
Closed -$1.8K 10125
2023
Q4
$1.8K Sell
1,522
-1,089
-42% -$1.24K ﹤0.01% 8223
2023
Q3
$2.74K Buy
2,611
+2,511
+2,511% +$2.26K ﹤0.01% 7653
2023
Q2
$76 Buy
+100
New +$80 ﹤0.01% 8547
2023
Q1
Sell
-4,938
Closed -$5.68K 10502
2022
Q4
$5.68K Buy
4,938
+3,676
+291% +$5.83K ﹤0.01% 9144
2022
Q3
$2K Buy
1,262
+549
+77% +$1.12K ﹤0.01% 9790
2022
Q2
$1K Sell
713
-638
-47% -$3.05K ﹤0.01% 9987
2022
Q1
$8K Sell
1,351
-4,431
-77% -$24K ﹤0.01% 8709
2021
Q4
$40K Buy
5,782
+3,974
+220% +$41.3K ﹤0.01% 7132
2021
Q3
$25K Buy
+1,808
New +$25.9K ﹤0.01% 6931

Other funds holding ZENV

UBS Group's ZENV Position: Q1 2026 in Review

UBS Group sold out of Zenvia (ZENV) in Q1 2026, closing a stake of 100 shares — an estimated $96 sold.

UBS Group first reported a position in ZENV in Q3 2021 and held it in 12 quarters. The position peaked at $40K in Q4 2021. 1 fund tracked by Wall St. Rank holds ZENV as of Q1 2026.

  • UBS Group reported no remaining Zenvia position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 100 Zenvia shares in Q1 2026, an estimated $96.
  • UBS Group first reported a position in Zenvia in Q3 2021 and held it in 12 quarters.
  • UBS Group's Zenvia position peaked at $40K in Q4 2021.
  • 1 fund tracked by Wall St. Rank held Zenvia as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.